Heart failure (HF) is a global public health problem that affects an estimated 64 million people worldwide.
1-3 In the US alone, more than 6 million patients have been diagnosed with HF and in excess of 1 million annual hospital admissions have had HF as a primary discharge diagnosis.
4 Despite the increasing burden of hospitalizations for worsening HF (WHF), our understanding of epidemiological factors, patient clinical characteristics, care management, and outcomes in patients admitted for WHF is based almost entirely on observational studies relying on administrative or claims data and/or national reporting databases or quality improvement registries.
4 However, these data sources are intrinsically limited by the accuracy and completeness of diagnostic coding and/or voluntary reporting. Furthermore, signs and symptoms of HF inherently lack sensitivity and specificity, and overlap occurs with other common cardiovascular and noncardiovascular conditions, raising the possibility of misclassification.
5